Literature DB >> 12878855

Targeting the kinetochore for mitosis-specific inhibitors.

S A Jablonski1, S T Liu, T J Yen.   

Abstract

Microtubule poisons such as taxol and vinblastine are widely used to treat a variety of cancers. These drugs are believed to kill cells by blocking mitosis. However, there is a critical need to identify new drugs because tumors can often become refractory to treatment with existing drugs. Studies over the past decade on chromosome segregation have uncovered a plethora of novel proteins that function specifically in mitosis. Centrosomes and kinetochores are two organelles that specify formation of the spindle and the attachment of chromosomes to the spindle, respectively. The focus of this review is to highlight the kinetochore as a rich source of targets for the development of mitosis-specific drugs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12878855     DOI: 10.4161/cbt.2.3.384

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  2 in total

Review 1.  Help or hindrance: how do microtubule-based forces contribute to genome damage and repair?

Authors:  Cassi Estrem; Jeffrey K Moore
Journal:  Curr Genet       Date:  2019-09-09       Impact factor: 3.886

2.  Identification of novel mitosis regulators through data mining with human centromere/kinetochore proteins as group queries.

Authors:  Aaron R Tipton; Kexi Wang; Peter Oladimeji; Shermeen Sufi; Zhidong Gu; Song-Tao Liu
Journal:  BMC Cell Biol       Date:  2012-06-19       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.